These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7222632

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Demonstration of influenza virus reproduction stages sensitive to remantadine.
    Kozeletskaya KN, Yukhnova LG, Zhukova TY, Guskin YR, Golubev DB.
    Virologie; 1980; 31(1):13-9. PubMed ID: 7189620
    [Abstract] [Full Text] [Related]

  • 24. [Variability of the virulent properties of influenza A viruses in recombination].
    Zazimko LA, Vakin VS, Kozinets IA, Zakharova NG.
    Vopr Virusol; 1982; 27(4):449-52. PubMed ID: 7135925
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effects of remantadine on fusion of lipid membranes of influenza A virus with plasma and internal membranes of lymphoblastic cells].
    Leneva IA, Gulak PV, Dubrov IuN, Sobolev AS.
    Biull Eksp Biol Med; 1990 May; 109(5):483-5. PubMed ID: 2378964
    [Abstract] [Full Text] [Related]

  • 30. [Effect of remantadine and amantadine on the interaction of influenza virus proteins with model lipid membranes].
    Kharitonenkov IG, El Karadaghi S, Fedorov AN, Zakomyrdin IuA, Tverdislov VA.
    Vopr Virusol; 1988 May; 33(1):22-6. PubMed ID: 3369145
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Low incidence of rimantadine resistance in field isolates of influenza A viruses.
    Ziegler T, Hemphill ML, Ziegler ML, Perez-Oronoz G, Klimov AI, Hampson AW, Regnery HL, Cox NJ.
    J Infect Dis; 1999 Oct; 180(4):935-9. PubMed ID: 10479115
    [Abstract] [Full Text] [Related]

  • 34. [The molecular mechanism of the action of antiviral preparations in the adamantane series].
    Kiselev OI, Blinov VM, Kozeletskaia KN, Il'enko VI, Platonov VG, Chupakhin ON, Stukova MA, Karginov VA.
    Vestn Ross Akad Med Nauk; 1993 Oct; (3):10-5. PubMed ID: 7687902
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [pH-dependent hemolytic and neuraminidase activity of remantadine-sensitive and -resistant variants of influenza virus].
    Kornilaeva GV, Molibog EV, Bukrinskaia AG.
    Vopr Virusol; 1983 Oct; 28(1):30-2. PubMed ID: 6845715
    [Abstract] [Full Text] [Related]

  • 37. Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.
    Bukrinskaya AG, Vorkunova NK, Pushkarskaya NL.
    J Gen Virol; 1982 May; 60(Pt 1):61-6. PubMed ID: 7097251
    [Abstract] [Full Text] [Related]

  • 38. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.
    Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W.
    N Engl J Med; 1989 Dec 21; 321(25):1696-702. PubMed ID: 2687687
    [Abstract] [Full Text] [Related]

  • 39. The importance of virus drug-resistance in the treatment of influenza with rimantadine.
    Kubar OI, Brjantseva EA, Nikitina LE, Zlydnikov DM.
    Antiviral Res; 1989 Dec 21; 11(5-6):313-5. PubMed ID: 2802572
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.